Huit malades sur dix réagissent au vaccin UCPVax. Pour rivaliser avec les géants du vaccin contre le cancer, Besançon doit ...
About 9% of adults hospitalized with RSV died in the hospital or within 30 days of discharge, according to preliminary data ...
A melanoma vaccine data leak wiped $24bn off Moderna before its Madrid presentation, despite a statistically strong Phase 3 ...
Get Clinical Trial News on Telangana Today, Clinical Trial latest news, Clinical Trial news, | Telangana Today ...
An mRNA-based melanoma vaccine has been shown to reduce the risk of death or cancer coming back by 42%. The trial tested the ...
Why Moderna stock sank 17% after leaked cancer vaccine data, as investors weighed incomplete Phase 3 results, valuation risks ...
A late-stage melanoma vaccine report that was posted online and quickly pulled is driving a violent repricing in Moderna ...
Active-duty Staff Sergeant Lance Castle, a decorated noncommissioned officer (NCO), didn’t just refuse the COVID-19 shot on religious grounds—he was severely ...
1d
Arbutus Announces FDA Clinical Hold is Lifted on IND Application for AB-101, an Oral PD-L1 Inhibitor
AB-101 is a proprietary oral PD-L1 inhibitor that has the potential to activate patients’ hepatitis B virus (“HBV”)-specific immune response by inhibiting PD-L1. AB-101 has completed a Phase 1a/1b ...
Targeted Formulations' in the Context of Japanese Clinical PracticeThe key point of this news is the update of antigens to match the circulating virus. However, it is necessary to distinguish between ...
In early September, Conservative Party MP Dean Allison held a four-day independent, unsanctioned “inquiry” for “Canadians to share their personal experiences of injuries…from the COVID-19 vaccine(s).” ...
MRNA expands beyond COVID-19 with new RSV, flu and combination vaccines, but fierce competition could challenge its efforts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results